Everyone screaming 100k is exit liquidity. I've seen this movie three times. Tightening stops, scaling out, letting the degens fight over the top. Wagmi until the wick.
Term sheets kill more startups than bad code. Founders sign 2x liquidation prefs then beg for bridge rounds.
I only back teams who negotiate like operators.
Read every clause or stay broke.
Patience isn't passive. It's the trade.
Chasing every candle is how accounts die. I wait for my level or I do nothing. Boring? Good. Boredom beats liquidation.
Still flat. Still fine.
72% of retail traders lose money. The rest just haven't exited yet. Round-tripping $PEPE to zero while blaming whales is a lifestyle, not a strategy. Your stop-loss is a suggestion. Stay humble, or stay rekt.
70% of crypto policy analysts never worked in crypto. Myth: they hate the industry. Reality: most just lack context. Bad rules come from bad exposure, not malice.
Patience isn't sexy but it pays. Everyone wants the bottom, nobody wants to sit still waiting for it. No setup, no trade. Hands off, levels loaded, wagmi. LFG when the chart says so, not before.
Hear us out: AI could make all of us a lot richer by lowering costs, boosting productivity, and giving people more of their time back. That’s the future worth building toward.
➡️https://t.co/XcEFNCnlxl
A $1B+ Solana vote was still failing with 8 seconds left on the clock. @DrNickA, Head of Governance at @JitoFDN, breaks down the trade-off behind the disinflation vote — and how close it actually came to failing.
Hm. Audits tell you what broke.
But commit history and admin key custody tell you if the team can even ship a fix. Most exploits are governance failures, not code failures.
What kind of operational infrastructure does coordination across the healthcare value chain actually require?
Eight years of building clinical programs across Southeast Asia, working with governments, hospital networks, and pharmaceutical companies, produced one consistent finding: the challenge is not the absence of capable AI. It is the absence of operational infrastructure that makes coordination reusable across programs.
Without that infrastructure, coordination remains highly program-specific, especially in drug development, where multiple key players must work together across the development process.
The infrastructure this requires has three properties.
It has to be reusable. Clinical programs should move from bespoke projects to reusable rails, with shared coordination rails replacing bespoke integration at every site.
It has to compound. Every application should strengthen the model, the network, and the protocol, building greater capacity across the ecosystem over time.
It has to enable coordination among independent actors. Hospitals, doctors, labs, pharma sponsors, regulators, patients, and AI builders can contribute services, validation, and clinical execution without surrendering operational sovereignty.
At Life AI, we are building an operating infrastructure for drug development around these requirements, bringing together AI-driven discovery, wet-lab screening, and clinical validation.
If you want to improve your game, a strong short game is imperative. Having confidence around the greens will improve your scoring. Having a strong base and keep your weight on your lead foot are important basics to get right. Spend more time chipping and putting and see how it impacts your game. GP
#PXGTroops